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There is a constantly growing body of evidence concern-
ing the pharmacological treatment of schizophrenia. For
example, the register of controlled trials of the Cochrane
Schizophrenia Group currently contains more than 8000
publications. In this context the lecture will present the
current state of the art of the pharmacological treatment of
schizophrenia, but using a step by step algorithm from the
choice of drug for the acutely patient to effective mainte-
nance treatment for relapse prevention. The following
points will be covered: choice of drug, typical versus atyp-
ical antipsychotics, which atypical antipsychotic, strate-
gies for agitated patients, negative symptoms, depression,
duration of an antipsychotic drug trial, strategies after ini-
tial non-response, clozapine, duration-, dose and choice
of drug in maintenance treatment. Methodological issues
in this competitive area will also be addressed.
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